This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: China Agricultural University. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Xiangbo Zhang: Innovator in Nucleic Acid Editing
Introduction
Xiangbo Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of genetic engineering, particularly in nucleic acid editing technologies. His innovative work has the potential to impact various applications in agriculture and medicine.
Latest Patents
Xiangbo Zhang holds a patent for the CRISPR/Cas12J enzyme and system. This patent includes a Cas effector protein, a fusion protein containing said protein, and a nucleic acid molecule coding for the same. Additionally, it provides a complex and a composition for nucleic acid editing, which can be utilized for gene or genome editing. The patent also outlines a method for nucleic acid editing using the Cas effector protein or the fusion protein.
Career Highlights
Xiangbo Zhang is affiliated with China Agricultural University, where he conducts research and development in the field of genetic engineering. His work has garnered attention for its innovative approach to gene editing, which is crucial for advancements in biotechnology.
Collaborations
Some of his notable coworkers include Jinsheng Lai and Yingsi Zhou. Their collaborative efforts contribute to the ongoing research and development in the field of nucleic acid editing.
Conclusion
Xiangbo Zhang is a key figure in the realm of genetic engineering, with his patent on the CRISPR/Cas12J enzyme showcasing his innovative contributions. His work at China Agricultural University continues to pave the way for advancements in nucleic acid editing technologies.